0.6700
-0.0020
(-0.30%)
At close: April 17 at 4:37:31 PM GMT+3
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
79,827.6820
29,017.2960
69,181.9210
39,509.0240
Investing Cash Flow
--
-113,641.8380
-27,620.8720
827.4960
-47,058.2630
Financing Cash Flow
--
-28,239.5340
-22,547.5620
-20,687.9830
-29,035.8160
End Cash Position
--
20,660.1900
82,713.8800
103,865.0180
54,543.5840
Capital Expenditure
--
-29,842.1370
-30,129.5690
-21,450.5010
-27,489.8220
Free Cash Flow
--
49,985.5450
-1,112.2730
47,731.4200
12,019.2020
12/31/2020 - 12/6/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRKC.SG Merck KGaA
22.80
-0.87%
MRKC.DU Merck KGaA
22.80
-0.87%
R5XA.BE AcelRx Pharmaceuticals Inc
0.4175
-2.22%
EVT.VI Evotec SE
6.24
+7.21%
BON.F Boiron SA
23.55
-1.05%
MRKC.F Merck KGaA
23.20
+0.87%
ATB.RO Antibiotice S.A.
2.0900
+0.72%
131030.KQ DHP Korea Co., Ltd.
6,230.00
-0.80%
MRKC.MU Merck KGaA
23.20
0.00%
EVT.DU Evotec SE
6.37
+9.87%